Home Page

CLEARWATER, Fla., Feb. 15, 2019 /PRNewswire/ -- From 1999 to 2016, the rate of suicides in the U.S. increased by 30 percent. It's now the second-leading cause of death for 10 to 34-year-olds. Social media bullying, increasing economic disparity, returning veterans traumatized by war, and unintended... Read more ››

SUZHOU, China, Feb. 15, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone") today announced that the National Medical Products Administration (NMPA) recently approved a Phase III clinical trial in China for its partnered drug candidate avapritinib as a third-line treatment against KIT-driven... Read more ››

HENNIGSDORF, Germany, Feb. 15, 2019 /PRNewswire/ --

LONDON, Feb. 15, 2019 /PRNewswire/ -- Healthcare knowledge provider BMJ has partnered with Editage to offer language editing and translation services to medical researchers who seek to publish in healthcare science journals.

REDWOOD CITY, Calif., Feb. 15, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that it has filed a lawsuit for patent infringement against Stimwave Technologies,... Read more ››

NEW YORK, Feb. 15, 2019 /PRNewswire/ -- Hoth Therapeutics Inc. ("Hoth" or the "Company"), a development stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema, today announced the pricing... Read more ››

AMSTERDAM, Feb. 15, 2019 /PRNewswire/ --

CHICAGO, Feb. 15, 2019 /PRNewswire/ -- According to the new market research report "Near Infrared Imaging Market by Product Type (NIR Fluorescence Imaging, Reagents), Application (Cancer surgery, Plastic surgery, Gastrointestinal surgery) End Users (Hospitals & Clinics, Research laboratory,... Read more ››

ANAHEIM, Calif., Feb. 15, 2019 /PRNewswire/ -- BioCorRx Inc. (BICX), based in Anaheim, CA, Leader in addiction treatment solutions and drug development implementation, today announced that Brady Granier, CEO/President and Lourdes Felix, CFO/COO, will present live at VirtualInvestorConferences.com... Read more ››

DENVER, Feb. 15, 2019 /PRNewswire/ -- The Colorado Mesothelioma Victims Center is appealing... Read more ››

EAST LIVERPOOL, Ohio, Feb. 15, 2019 /PRNewswire/ -- FRX Health(TM) is excited to announce the opening of its Ohio Dispensary on February 7(th), 2019. FRX Health was awarded a license by Ohio's Medical Marijuana Control Program last summer. The Dispensary is located at 1865 Dresden Avenue in East... Read more ››

PHOENIX, Feb. 15, 2019 /PRNewswire/ -- The American Council for Patient Liberty created a website and produced an educational video to inform Arizonans and elected officials about voter protected medical marijuana as well as hemp extracts in Arizona. House Bill 2149 sponsored by Representative... Read more ››

INDIANAPOLIS, Feb. 15, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today announced the successful completion of its acquisition of Loxo Oncology, Inc. (NASDAQ:LOXO). The acquisition broadens the scope of Lilly's oncology portfolio into precision medicines through the addition of a pipeline... Read more ››

WHIPPANY, N.J., Feb. 15, 2019 /PRNewswire/ -- Bayer has exercised its option, under a change-in-control clause in the collaboration agreement with Loxo Oncology, to obtain the exclusive licensing rights for the global development and commercialization, for Vitrakvi® (larotrectinib) and BAY 2731954... Read more ››

SILVER SPRING, Md., Feb. 15, 2019 /PRNewswire/ -- In too many cases, branded drugs that are no longer protected by patents or other exclusivities do not face expected competition. In fact, there are several hundred of such branded drugs that do not have any generic competition. Instances... Read more ››

SILVER SPRING, Md., Feb. 15, 2019 /PRNewswire/ -- "We're at an inflection point when it comes to cell and gene therapies. These treatments have the potential to address hundreds of vexing human diseases and conditions. When we first issued our comprehensive regenerative medicine policy framework... Read more ››